Search | LIFE-ND Graduate Community

added blog Health

2026-06-23 09:11:49 -

The Trastuzumab Biosimilar Market is witnessing substantial growth as healthcare systems seek cost-effective alternatives to branded Herceptin for HER2-positive cancer treatment. Trastuzumab biosimilars replicate the therapeutic effects of the reference biologic while offering significant cost savings to patients and providers. The market encompasses multiple approved biosimilars targeting...

0 Comments 0 Shares 80 Views 0 Reviews